Key result
Review examines how modern interventional and pharmaceutical therapies impact morbidity and mortality in women with CAD.
This review discusses the interaction between coronary disease and female gender in the context of modern therapeutic approaches.
Answers are grounded in this paper and cite their sources.
Emphasizes CAD outcome disparities in women; leaves open whether modern therapies close gender gaps.
In recent years attention has been raised to the fact of increased morbidity and mortality between women who suffer from coronary disease. The identification of the so called Yentl Syndrome has emerged the deeper investigation of the true incidence of coronary disease in women and its outcomes. In this review an effort has been undertaken to understand the interaction of coronary disease and female gender after the implementation of newer therapeutic interventional and pharmaceutics' approaches of the modern era.
No takes yet. Share an insight, caveat, or question.
Sofia Vaina (2015) conducted a review in Coronary artery disease. Contemporary interventional and pharmaceutical therapies was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: